"Sensor-based glucose monitoring has transformed diabetes care," said Akshay Jain, M.D., a nationally recognized endocrinologist based in Surrey, British Columbia. "These intuitive tools, like the ...

Coverage means more Canadians with diabetes can access Abbott's sensor-based glucose technology, giving them actionable insights to manage their condition confidently, i "Sensor-based glucose ...

Abbott, the creator of continuous glucose monitors, launched the new Assist feature at CES 2026. Part of the Libre app, it aims to help people with diabetes take the guesswork out of how food affects ...

The monitors were giving incorrect, low readings.

Anthony Bourdain was known for his exploration of other cultures through their foods and customs, but he occasionally got ...

AMAT rides a semiconductor rebound as systems, services and ICAPS drive gains, even as China export curbs, memory lag and ...

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

TD Cowen analysts Mathew Blackman and Drew Ranieri have named their top three medtech picks under their evolving “Bones, Bots ...

'It was a miracle I was diagnosed to begin with.' ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...

'It was a miracle I was diagnosed to begin with.' ...